These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11449873)

  • 1. Researchers urge caution with standard regimen for metastatic colorectal cancer.
    Traynor K
    Am J Health Syst Pharm; 2001 Jul; 58(13):1180. PubMed ID: 11449873
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.
    Sargent DJ; Niedzwiecki D; O'Connell MJ; Schilsky RL
    N Engl J Med; 2001 Jul; 345(2):144-5; author reply 146. PubMed ID: 11450666
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.
    Ledermann JA; Leonard P; Seymour M
    N Engl J Med; 2001 Jul; 345(2):145-6. PubMed ID: 11450667
    [No Abstract]   [Full Text] [Related]  

  • 4. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Erlichman C; Goldberg RM; O'Connell MJ
    N Engl J Med; 2001 Jan; 344(4):305; author reply 306-7. PubMed ID: 11191661
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicity of irinotecan in patients with colorectal cancer.
    Van Cutsem E; Douillard JY; Köhne CH
    N Engl J Med; 2001 Nov; 345(18):1351-2. PubMed ID: 11794165
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant irinotecan regimens in combination with infusional 5-fluorouracil/leucovorin fail to improve outcomes in surgically resected colorectal cancer.
    Tyagi P
    Clin Colorectal Cancer; 2005 Jul; 5(2):86-8. PubMed ID: 16098248
    [No Abstract]   [Full Text] [Related]  

  • 8. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Pignon JP; Ducreux M
    N Engl J Med; 2001 Jan; 344(4):306; author reply 306-7. PubMed ID: 11191663
    [No Abstract]   [Full Text] [Related]  

  • 9. [Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].
    Motomura S
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():360-3. PubMed ID: 14574913
    [No Abstract]   [Full Text] [Related]  

  • 10. [Initial results of randomized studies of metastatic colorectal carcinoma urge careful and controlled use of CPT-11].
    Klautke G; Fietkau R
    Strahlenther Onkol; 2002 Mar; 178(3):163-4. PubMed ID: 11962194
    [No Abstract]   [Full Text] [Related]  

  • 11. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Vaiani M; Trippoli S; Messori A
    N Engl J Med; 2001 Jan; 344(4):305-6; author reply 306-7. PubMed ID: 11191660
    [No Abstract]   [Full Text] [Related]  

  • 12. Irinotecan and 5-FU/ leucovorin in metastatic colorectal cancer: balancing efficacy, toxicity, and logistics.
    Hwang JJ
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):26-34. PubMed ID: 15685831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
    Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Fruth B; Meyerhardt JA; Schrag D; Greene C; O'Neil BH; Atkins JN; Berry S; Polite BN; O'Reilly EM; Goldberg RM; Hochster HS; Schilsky RL; Bertagnolli MM; El-Khoueiry AB; Watson P; Benson AB; Mulkerin DL; Mayer RJ; Blanke C
    JAMA; 2017 Jun; 317(23):2392-2401. PubMed ID: 28632865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer.
    Kono T; Ebisawa Y; Tomita I; Chisato N; Kamiya K; Asama T; Ayabe T; Ashida T; Kohgo Y; Kasai S
    J Chemother; 2005 Apr; 17(2):224-7. PubMed ID: 15920910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin.
    Bleiberg H; Di Leo A
    J Clin Oncol; 2002 Feb; 20(4):1145-6. PubMed ID: 11844840
    [No Abstract]   [Full Text] [Related]  

  • 16. Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer.
    Fisher MD
    Clin Colorectal Cancer; 2001 Aug; 1(2):82-4. PubMed ID: 12445364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Capecitabine and irinotecan].
    Gasperoni S
    Suppl Tumori; 2004; 3(4):S107-8. PubMed ID: 15206231
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer.
    Kim JW; Lee KW; Kim KP; Lee JH; Hong YS; Kim JE; Kim SY; Park SR; Nam BH; Cho SH; Chung IJ; Park YS; Oh HS; Lee MA; Kang HJ; Park YI; Song EK; Han HS; Lee KT; Shin DB; Kang JH; Zang DY; Kim JH; Kim TW
    Oncologist; 2017 Mar; 22(3):293-303. PubMed ID: 28209749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified-irinotecan/fluorouracil/levoleucovorin therapy as ambulatory treatment for metastatic colorectal cancer: results of phase I and II studies.
    Yuuki S; Komatsu Y; Fuse N; Kato T; Miyagishima T; Kudo M; Watanabe M; Tateyama M; Kunieda Y; Wakahama O; Sakata Y; Asaka M
    Clin Drug Investig; 2010; 30(4):243-9. PubMed ID: 20225907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N9741: a phase III study comparing irinotecan to oxaliplatin-containing regimens in advanced colorectal cancer.
    Goldberg RM
    Clin Colorectal Cancer; 2002 Aug; 2(2):81. PubMed ID: 12453321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.